Headache Study to Compare Aggrenox Full Dose and Reduced Dose

NCT00274586 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebrovascular Accident

Interventions

DRUG: Aggrenox® modified release capsules
DRUG: Aggrenox® modified release capsules matching placebo

Sponsor

Boehringer Ingelheim